Major manufacturing investment to support API production for tirzepatide
Eli Lilly and Company has committed the largest US investment in synthetic medicine active pharmaceutical ingredient (API) manufacturing.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
